| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2023/06/29 | 20 : 01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/06/28 | 20 : 01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/06/17 | 05 : 35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/06/17 | 05 : 35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/06/17 | 05 : 31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/06/13 | 23 : 32 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/06/13 | 06 : 01 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/06/09 | 22 : 02 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/06/02 | 05 : 02 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/05/24 | 22 : 31 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/05/23 | 22 : 31 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/05/12 | 06 : 23 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/05/12 | 06 : 21 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/05/03 | 05 : 05 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/04/29 | 06 : 17 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/04/29 | 06 : 16 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/04/29 | 06 : 12 | Edgar (US Regulatory) | Annual Report to Security Holders (ars) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/04/22 | 06 : 14 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/04/20 | 21 : 10 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/04/18 | 00 : 10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/04/15 | 06 : 01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/04/15 | 05 : 14 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/04/15 | 05 : 12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/04/15 | 05 : 12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/04/15 | 05 : 10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/04/15 | 05 : 10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/04/15 | 05 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/04/15 | 05 : 07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/04/15 | 05 : 07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
| 2023/04/12 | 20 : 02 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTI | Proteostasis Therapeutics Inc |
